Evidence map›Paper›PMID 31860766›Full record

ReviewClinical & experimental ophthalmology2020

Local delivery of corticosteroids in clinical ophthalmology: A review.

Adrian T Fung, Tuan Tran, Lyndell L Lim, Chameen Samarawickrama, Jennifer Arnold, Mark Gillies, Caroline Catt, Logan Mitchell, Andrew Symons, Robert Buttery and 3 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Clinical & experimental ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07449000 (Topical Losartan as Treatment to Reduce Corneal Scarring Fibrosis), which is not on this map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07449000 narecruitingnot on this mapstarted 2026, after this paper: background citation

Topical Losartan as Treatment to Reduce Corneal Scarring Fibrosis

TypeinterventionalSponsorUniversidad Autonoma de Nuevo LeonRan2026 to 2027Enrolled46ConditionsCorneal Scarring FibrosisArmsTopical losartan, Placebo Control
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Topical Treatment for Retinal Degenerative Pathologies: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Adrian T FungWestmead Clinical School, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-1117-3893
Tuan TranSave Sight Institute, Central Clinical School, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-0853-2226
Lyndell L LimRoyal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Chameen SamarawickramaWestmead Clinical School, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Jennifer ArnoldMarsden Eye Specialists, Sydney, New South Wales, Australia.
Mark GilliesSave Sight Institute, Central Clinical School, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Caroline CattSave Sight Institute, Central Clinical School, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Logan MitchellUniversity of Otago, Dunedin, New Zealand.
Andrew SymonsRoyal Melbourne Hospital, Melbourne, Victoria, Australia.
Robert ButteryMelbourne Retina Associates, Melbourne, Victoria, Australia.
Lisa CotteeEye Doctors Mona Vale, Sydney, New South Wales, Australia.
Krishna TumuluriWestmead Clinical School, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, New South Wales, Australia.
Paul BeaumontEye Doctors Mona Vale, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Locally administered steroids have a long history in ophthalmology for the treatment of inflammatory conditions. Anterior segment conditions tend to be treated with topical steroids whilst posterior segment conditions generally require periocular, intravitreal or systemic administration for penetration. Over recent decades, the clinical applications of periocular steroid delivery have expanded to a wide range of conditions including macular oedema from retino-vascular conditions. Formulations have been developed with the aim to provide practical, targeted, longer-term and more efficacious therapy whilst minimizing side effects. Herein, we provide a comprehensive overview of the types of periocular steroid delivery, their clinical applications in ophthalmology and their side effects.

Indexed as

GlucocorticoidsMacular EdemaOphthalmologyAdrenal Cortex HormonesHumansAdrenal Cortex HormonesGlucocorticoidscorticosteroiddexamethasoneFluocinolone acetonideprednisolone acetatetriamcinolone acetonide

Identifiers

PMID31860766
PMCPMC7187156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.